CRISPR Therapeutics AG (CRSP) BofA Securities 2024 Health Care Conference (Transcript)Seeking Alpha • 05/15/24
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to KnowZacks Investment Research • 05/13/24
CRISPR Therapeutics to Present at the Bank of America Securities Health Care ConferenceGlobeNewsWire • 05/09/24
CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/08/24
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial ResultsGlobeNewsWire • 05/08/24
CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing ApproachGlobeNewsWire • 05/08/24
CRISPR Therapeutics AG (CRSP) Outperforms Broader Market: What You Need to KnowZacks Investment Research • 05/03/24
Crispr Therapeutics: Market Misunderstanding Is Your Buying Opportunity (Upgrade)Seeking Alpha • 05/03/24
Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending StockZacks Investment Research • 05/01/24
CRISPR Therapeutics AG (CRSP) Ascends But Remains Behind Market: Some Facts to NoteZacks Investment Research • 04/26/24
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's WhyZacks Investment Research • 04/22/24
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual MeetingGlobeNewsWire • 04/22/24